This inventor holds 1 USPTO granted patent. Top assignee: Shionogi Company Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Yasuharu Kato: Innovator in Nucleic Acid Medicine
Introduction
Yasuharu Kato is a prominent inventor based in Toyonaka, Japan. He has made significant contributions to the field of nucleic acid medicine, focusing on improving therapeutic effects through innovative complexes.
Latest Patents
Kato holds a patent for a "Complex of nucleic acid medicine and multibranched lipid." The purpose of this invention is to provide novel complexes that enhance the efficacy of nucleic acid medicines. This complex involves a multibranched lipid that binds through a linker to a strand of an oligonucleotide, which comprises a nucleic acid medicine that suppresses the expression of target genes. He has 1 patent to his name.
Career Highlights
Yasuharu Kato is associated with Shionogi Company Limited, where he continues to work on groundbreaking research in the pharmaceutical field. His innovative approach has positioned him as a key figure in the development of advanced medical therapies.
Collaborations
Kato has collaborated with notable colleagues, including Norikazu Kuroda and Mitsuaki Sekiguchi. Their combined expertise has contributed to the advancement of their research projects.
Conclusion
Yasuharu Kato's work in nucleic acid medicine exemplifies the impact of innovative thinking in healthcare. His contributions are paving the way for more effective treatments in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile